Home › Companies › UNITED THERAPEUTICS CORP. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and UNITED THERAPEUTICS CORP.’s Form 8-K, filed June 27, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 26, 2025: 15 items on UNITED THERAPEUTICS CORP.’s Form 8-K, filed June 27, 2025: 15 passed (calculated).
Notable dissent: 2 directors (13.2%, 11.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore UNITED THERAPEUTICS CORP. in the interactive database Compare manager voting policies
These tallies are UNITED THERAPEUTICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Christopher Causey | 34,893,687 | 5,296,661 | 16,365 | -- | 1,296,357 | 87% | Passed (calculated) | — |
| Elect Director: Raymond Dwek | 36,254,579 | 3,935,774 | 16,360 | -- | 1,296,357 | 90% | Passed (calculated) | — |
| Elect Director: Richard Giltner | 37,971,706 | 2,218,884 | 16,123 | -- | 1,296,357 | 94% | Passed (calculated) | — |
| Elect Director: Ray Kurzweil | 38,353,526 | 1,836,845 | 16,342 | -- | 1,296,357 | 95% | Passed (calculated) | — |
| Elect Director: Jan Malcolm | 39,688,758 | 500,264 | 17,691 | -- | 1,296,357 | 99% | Passed (calculated) | — |
| Elect Director: Linda Maxwell | 39,715,114 | 474,450 | 17,149 | -- | 1,296,357 | 99% | Passed (calculated) | — |
| Elect Director: Nilda Mesa | 39,346,176 | 833,067 | 27,470 | -- | 1,296,357 | 98% | Passed (calculated) | — |
| Elect Director: Judy Olian | 39,832,045 | 357,023 | 17,645 | -- | 1,296,357 | 99.1% | Passed (calculated) | — |
| Elect Director: Christopher Patusky | 35,613,212 | 4,577,171 | 16,330 | -- | 1,296,357 | 89% | Passed (calculated) | — |
| Elect Director: Martine Rothblatt | 37,651,671 | 2,539,840 | 15,202 | -- | 1,296,357 | 94% | Passed (calculated) | — |
| Elect Director: Louis Sullivan | 36,302,169 | 3,875,030 | 29,514 | -- | 1,296,357 | 90% | Passed (calculated) | — |
| Elect Director: Tommy Thompson | 38,598,138 | 1,590,040 | 18,535 | -- | 1,296,357 | 96% | Passed (calculated) | — |
| 2. Advisory resolution to approve executive compensation | 38,413,776 | 1,763,712 | 29,225 | -- | 1,296,357 | 96% | Passed (calculated) | — |
| 3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan | 36,901,484 | 3,277,695 | 27,534 | -- | 1,296,357 | 92% | Passed (calculated) | — |
| 4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025 | 39,345,917 | 2,142,852 | 14,301 | -- | -- | 95% | Passed (calculated) | — |
Source: UNITED THERAPEUTICS CORP., Form 8-K, filed with the SEC on June 27, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
639 asset managers disclosed a vote on at least one UNITED THERAPEUTICS CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Prior year: 86.7% for (June 26, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: Election of Directors: Christopher Causey
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Causey”): 34,893,687 for, 5,296,661 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 15,721,586 for, 1,290,959 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,457 | 1 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 2,671 | 720,613 | 0 | 0 | Against |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 0 | 232,026 | 0 | 0 | Against |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 11,864 | 84,366 | 0 | 0 | Mixed |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Brighthouse | 67,157 | 482 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Prior year: 89.4% for (June 26, 2024 meeting) ▼ 0.8 pts
Description as filed by funds: Election of Directors: Christopher Patusky
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Christopher Patusky”): 35,613,212 for, 4,577,171 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 16,239,791 for, 776,999 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,457 | 1 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 2,671 | 720,613 | 0 | 0 | Against |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.6% for (June 26, 2024 meeting) ▼ 0.8 pts
Description as filed by funds: Election of Directors: Jan Malcolm
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Jan Malcolm”): 39,688,758 for, 500,264 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 16,982,074 for, 34,716 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,284 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Prior year: 99.2% for (June 26, 2024 meeting) unchanged
Description as filed by funds: Election of Directors: Judy Olian
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Judy Olian”): 39,832,045 for, 357,023 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 17,015,067 for, 1,723 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,284 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 99.0% for (June 26, 2024 meeting) ▼ 0.2 pts
Description as filed by funds: Election of Directors: Linda Maxwell
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Linda Maxwell”): 39,715,114 for, 474,450 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 17,016,789 for, 0 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,284 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 91.4% for (June 26, 2024 meeting) ▼ 1.0 pts
Description as filed by funds: Election of Directors: Louis Sullivan
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Louis Sullivan”): 36,302,169 for, 3,875,030 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 16,241,263 for, 775,527 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,457 | 1 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 2,671 | 720,613 | 0 | 0 | Against |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 93.5% for (June 26, 2024 meeting) ▲ 0.2 pts
Description as filed by funds: Election of Directors: Martine Rothblatt
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Martine Rothblatt”): 37,651,671 for, 2,539,840 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 16,947,609 for, 69,181 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,240 | 44 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 147,576 | 36,433 | 0 | 0 | Mixed |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.4% for (June 26, 2024 meeting) ▲ 0.5 pts
Description as filed by funds: Election of Directors: Nilda Mesa
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Nilda Mesa”): 39,346,176 for, 833,067 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 17,011,275 for, 5,515 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,284 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 92.6% for (June 26, 2024 meeting) ▲ 2.8 pts
Description as filed by funds: Election of Directors: Ray Kurzweil
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Ray Kurzweil”): 38,353,526 for, 1,836,845 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 16,950,303 for, 66,487 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,240 | 44 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 91.7% for (June 26, 2024 meeting) ▼ 1.5 pts
Description as filed by funds: Election of Directors: Raymond Dwek
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Raymond Dwek”): 36,254,579 for, 3,935,774 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 16,198,893 for, 817,897 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,457 | 1 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 2,671 | 720,613 | 0 | 0 | Against |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 95.4% for (June 26, 2024 meeting) ▼ 0.9 pts
Description as filed by funds: Election of Directors: Richard Giltner
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Richard Giltner”): 37,971,706 for, 2,218,884 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 16,975,950 for, 40,840 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,240 | 44 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 96.3% for (June 26, 2024 meeting) ▼ 0.3 pts
Description as filed by funds: Election of Directors: Tommy Thompson
UNITED THERAPEUTICS CORP.’s own tally for this item (“Elect Director: Tommy Thompson”): 38,598,138 for, 1,590,040 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 153 asset managers below reported 16,979,741 for, 37,049 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,240 | 44 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 153 asset managers. All 153 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Prior year: 87.6% for (June 26, 2024 meeting) ▲ 4.2 pts
Description as filed by funds: APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE UNITED THERAPEUTICS CORPORATION AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN.
UNITED THERAPEUTICS CORP.’s own tally for this item (“3. Approval of the amendment and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan”): 36,901,484 for, 3,277,695 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,395,458 | 0 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,240 | 44 | 0 | 0 | For |
| Pacer Funds Trust | 0 | 500,680 | 0 | 0 | Against |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 11,864 | 84,366 | 0 | 0 | Mixed |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Fund voting reports, all 148 managers: 16,119,905 for, 811,060 against, 12,176 abstained, 22 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Eversept Partners, LP | 130,366 | 0 | 0 | 0 | For |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 0 | 33,900 | 0 | 0 | Against |
| Erste Asset Management GmbH | 25,341 | 0 | 0 | 0 | For |
| Cardano Risk Management B.V. | 18,794 | 0 | 0 | 0 | For |
| Decatur Capital Management, Inc. | 7,709 | 0 | 0 | 0 | For |
| OSSIAM | 1,456 | 0 | 0 | 0 | For |
| EAGLE GLOBAL ADVISORS LLC | 500 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 0 | 444 | 0 | 0 | Against |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 0 | 0 | 0 | 0 | -- |
| Hendershot Investments Inc. | 0 | 200 | 0 | 0 | Against |
| BRANDYWINE OAK PRIVATE WEALTH LLC | 81 | 0 | 0 | 0 | For |
Institutional-manager reports, all 11 managers: 184,247 for, 34,544 against, 411 unknown.
Combines 12 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 94.8% for (June 26, 2024 meeting) ▲ 0.9 pts
Description as filed by funds: Advisory resolution to approve executive compensation.
UNITED THERAPEUTICS CORP.’s own tally for this item (“2. An advisory resolution to approve executive compensation”): 38,413,776 for, 1,763,712 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of UNITED THERAPEUTICS CORP.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Compensation” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,394,860 | 598 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,284 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 156,580 | 1,838 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 86,146 | 7,400 | 0 | 0 | Mixed |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,884 | 0 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Fund voting reports, all 148 managers: 16,846,766 for, 94,290 against, 12,176 abstained, 22 not voted. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,009,396 | 293 | 0 | 0 | For |
| State Street | 1,948,616 | 0 | 0 | 0 | For |
| Wellington | 1,815,496 | 0 | 0 | 0 | For |
| Renaissance | 1,644,957 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 1,249,329 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,217,495 | 0 | 0 | 0 | For |
| Fidelity | 1,208,421 | 0 | 0 | 0 | For |
| AQR | 562,904 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 523,185 | 0 | 0 | 0 | For |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 518,236 | 0 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 474,881 | 0 | 0 | 0 | For |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 209,748 | 209,748 | 0 | 0 | Mixed |
| Invesco | 403,003 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 386,744 | 0 | 0 | 0 | For |
| Charles Schwab | 354,590 | 0 | 0 | 0 | For |
| Amundi | 0 | 345,482 | 0 | 0 | Against |
| AllianceBernstein | 343,860 | 0 | 0 | 0 | For |
| Northern Trust | 335,044 | 0 | 0 | 0 | For |
| Swedbank Robur Fonder AB | 321,405 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 310,849 | 0 | 0 | 0 | For |
| Epoch Investment Partners, Inc. | 288,484 | 0 | 0 | 0 | For |
| AustralianSuper Pty Ltd | 284,616 | 0 | 0 | 0 | For |
| Nuveen | 274,092 | 0 | 0 | 0 | For |
| ASSETMARK, INC | 270,061 | 952 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 261,991 | 0 | 0 | 0 | For |
Institutional-manager reports, all 518 managers: 25,161,587 for, 1,376,715 against, 6,057 abstained, 1,620 not voted, 411 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 96.4% for (June 26, 2024 meeting) ▼ 1.6 pts
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025.
UNITED THERAPEUTICS CORP.’s own tally for this item (“4. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025”): 39,345,917 for, 2,142,852 against, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 152 asset managers below reported 16,971,460 for, 26,536 against, 12,176 abstained, 22 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,394,860 | 598 | 0 | 0 | For |
| BlackRock | 2,949,135 | 0 | 0 | 0 | For |
| Fidelity | 2,104,599 | 0 | 0 | 0 | For |
| State Street | 723,240 | 44 | 0 | 0 | For |
| Pacer Funds Trust | 500,680 | 0 | 0 | 0 | For |
| Capitol Series Trust | 455,457 | 0 | 0 | 0 | For |
| Charles Schwab | 349,369 | 0 | 0 | 0 | For |
| Invesco | 331,976 | 0 | 0 | 0 | For |
| First Trust | 306,613 | 0 | 0 | 0 | For |
| Victory Capital | 303,730 | 0 | 0 | 0 | For |
| TIAA | 232,026 | 0 | 0 | 0 | For |
| Lord Abbett | 220,514 | 0 | 0 | 0 | For |
| Thrivent | 203,833 | 0 | 0 | 0 | For |
| John Hancock | 184,009 | 0 | 0 | 0 | For |
| AQR | 169,911 | 0 | 0 | 0 | For |
| SEI | 158,418 | 0 | 0 | 0 | For |
| JPMorgan | 112,335 | 0 | 0 | 0 | For |
| Jackson National | 96,230 | 0 | 0 | 0 | For |
| Dimensional | 95,632 | 0 | 0 | 0 | For |
| T. Rowe Price | 93,546 | 0 | 0 | 0 | For |
| Equitable | 83,150 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,655 | 0 | 0 | 0 | For |
| Brighthouse | 71,402 | 482 | 0 | 0 | For |
| AllianceBernstein | 71,517 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 62,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 152 asset managers. All 152 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 45,074,551 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 11.97% |
| 2 | BlackRock | 6.54% |
| 3 | Fidelity | 4.67% |
| 4 | State Street | 1.60% |
| 5 | Pacer Funds Trust | 1.11% |
| 6 | Capitol Series Trust | 1.01% |
| 7 | Charles Schwab | 0.78% |
| 8 | Invesco | 0.74% |
| 9 | First Trust | 0.68% |
| 10 | Victory Capital | 0.67% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 4.46% |
| 2 | State Street | 4.32% |
| 3 | Wellington | 4.03% |
| 4 | Renaissance | 3.65% |
| 5 | Avoro Capital Advisors LLC | 2.77% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.70% |
| 7 | Fidelity | 2.68% |
| 8 | AQR | 1.25% |
| 9 | LSV ASSET MANAGEMENT | 1.16% |
| 10 | CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 1.15% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 5,446,092 | 12.08% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 4,457,135 | 9.89% | Form 13F, quarter ended March 31, 2025 |
| Martine Rothblatt | 3,193,762 | 7.09% | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| Avoro Capital Advisors LLC | 2,858,888 | 6.34% | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| FMR LLC | 2,321,039 | 5.15% | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| State Street | 2,230,708 | 4.95% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 2,106,992 | 4.67% | Form 13F, quarter ended March 31, 2025 |
| Wellington Management | 2,026,416 | 4.50% | Form 13F, quarter ended March 31, 2025 |
| FMR (Fidelity) | 1,144,603 | 2.54% | Form 13F, quarter ended March 31, 2025 |
| Dimensional Fund Advisors | 624,711 | 1.39% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 45,074,551 shares outstanding, as reported by UNITED THERAPEUTICS CORP. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At UNITED THERAPEUTICS CORP.'s shareholder meeting held June 26, 2025, in the 2024-2025 proxy season, 639 asset managers reported votes on at least one of its 15 ballot items in their SEC Form N-PX filings, covering 10,859 separate fund positions. On the most widely held item on that ballot — Advisory resolution to approve executive compensation. — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: UNITED THERAPEUTICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 27, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UNITED THERAPEUTICS CORP.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
UNITED THERAPEUTICS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “UNITED THERAPEUTICS (UTHR) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/united-therapeutics-corp/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.